In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora (COR – Research Report), with a price ...
Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading ...
Analyst Charles Rhyee of TD Cowen maintained a Buy rating on Cencora (COR – Research Report), with a price target of $288.00. Charles ...
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.
CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal fourth-quarter net income of $3.4 million. On a per-share basis, the Conshohocken ...
Cencora, Inc. reported significant growth in its fiscal 2024 results, boasting a 14.7% increase in fourth-quarter revenue to $79.1 billion and a 12.1% rise for the year to $294.0 billion.
Hosted on MSN7mon
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?For the current fiscal year, Cencora is expected to post earnings of $13.43 per share on $292.23 billion in revenues. This represents a 12.01% change in EPS on a 11.47% change in revenues. For the ...
Cencora ( NYSE:COR ) Full Year 2024 Results Key Financial Results Revenue: US$294.0b (up 12% from FY 2023). Net income... Cencora, Inc.'s ( NYSE:COR ) dividend will be increasing from last year's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
